Synthetic Biology Market Trends

ID: MRFR/HC/9417-HCR

200 Pages

Rahul Gotadki

October 2025

Synthetic Biology Market Size, Growth Research Report By Application (Healthcare, Industrial Biotechnology, Agriculture, Environmental Applications, Food and Nutrition), By Technology (Gene Synthesis, Gene Editing, Synthetic Genomics, Metabolic Engineering, Cloning), By Product Type (Synthetic Genes, Enzymes, Chassis Organisms, Nucleotides, Bioinformatics Tools), By End-use Industry (Pharmaceuticals, Biochemicals, Crop Production, Biofuels, Food and Beverage), and By Regional (North America, Europe, South America, Asia Pacific, Middle East a... read more

Request Free Sample

Summary Table of Contents Segmentation Download PDF

Market Trends

Key Emerging Trends in the Synthetic Biology Market

The change of the synthetic biology market is being impelled by innovative headways and interdisciplinary joint efforts. This is working with the plan and gathering of custom DNA, which is tracking down applications in modern biotechnology and helpful mediations. Because of their exact and designated genome altering capacities, CRISPR-based quality altering methods are acquiring acknowledgment, changing hereditary designing for the progression of GMOs, quality treatments, and utilitarian genomics research, and empowering quality adjustment with a remarkable level of precision. Designing microorganisms for incomprehensible modern applications, for example, biofuels, specialty synthetic compounds, and drugs, with the objective of bio-based, maintainable substitutions and expanded creation productivity, is the focal point of the synthetic biology market. The use of synthetic biology in farming includes the improvement of hereditarily adjusted crops that have upgraded attributes like protection from bugs, natural kind disposition, and dietary benefit. This try looks to work on horticultural practices and improve worldwide food security. The synthetic biology industry is embracing democratization as organizations give practical and easy to understand hereditary designing arrangements, which advances development and speeds up the execution of designed natural frameworks in a great many logical fields. A thriving pattern, without cell synthetic biology empowers researchers to direct tests without the utilization of living cells, while likewise giving benefits, for example, fast prototyping, adaptable response control, and counterfeit circuit plan. Synthetic biology is upsetting the clinical field through the advancement of customized medication and quality treatments. The utilization of designed cells and quality circuits to treat malignant growth, hereditary issues, and different sicknesses prepares for the advancement of altered mediations in complex clinical circumstances. The utilization of synthetic biology in natural settings, explicitly bioremediation and bioenergy creation, is expanding. This is because of its capacity to work with the corruption of contaminations, purge environments, and produce biofuels from sustainable assets. Via mechanizing the plan assemble test-learn cycle, dissecting huge datasets, and foreseeing prime hereditary plans, synthetic biology and simulated intelligence are changing organic plan, consequently speeding up disclosure and enhancement. Synthetic biology organizations, scholastic foundations, and industry areas are teaming up in a powerful biological system for extending applications to encourage development, work with the trading of information, and tackle complex difficulties. The moral talk encompassing hereditary designing, ecological effect, and guideline is common in the synthetic biology market, which exhibits a devotion to the capable and practical improvement of manufactured science advances. As administrative systems and guidelines adjust to manufactured science applications, wellbeing and morals concerns are acquiring unmistakable quality, highlighting the criticality of administrative oversight.

Market Highlights

Author

Rahul Gotadki

Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

FAQs

What is the projected growth of the Synthetic biology market?

The Synthetic biology market is the expected increase in total market value of 234.78 USD billion over a defined forecast period 2025–2035. It is driven by factors such as demand trends, technological advances, regulatory changes, and geographic expansion.

What is the size of the Synthetic biology market?

Synthetic biology market size was valued at approximately 18.63 billion USD in 2024. This figure will reach 234.78 billion USD covering all regions (America, Europe, Asia, MEA and ROW), focusing its segments / services / distribution channels till 2035.

What is the CAGR of the Synthetic biology market?

Synthetic biology market is expected to grow at a CAGR of 25.9% between 2025 and 2035.

How much will the Synthetic biology market be worth by 2035?

Synthetic biology market is expected to be worth of 234.78 billion USD, reflecting growth driven by usage, technology and global demands by the end of 2035.

How will the Synthetic biology market perform over the next 10 years?

Over the next 10 years the Synthetic biology market is expected to shift from usd billion 18.63 to 234.78 billion USD, led by adoption of advanced tech, demographic trends, regulatory approvals, with potential headwinds from 2025 to 2035.

What was the market size of the Synthetic Biology Market in 2024?

The Synthetic Biology Market was valued at 11.49 USD Billion in 2024.

How much is the Synthetic Biology Market projected to grow by 2035?

By 2035, the Synthetic Biology Market is projected to reach a value of 40.2 USD Billion.

Which region is expected to dominate the Synthetic Biology Market by 2035?

North America is expected to dominate the Synthetic Biology Market with a valuation of 16.5 USD Billion by 2035.

What will be the market size for the Healthcare application of Synthetic Biology in 2035?

The Healthcare application of Synthetic Biology is projected to be valued at 11.6 USD Billion by 2035.

Which key players are leading the Synthetic Biology Market?

Key players in the Synthetic Biology Market include Ginkgo Bioworks, Regeneron Pharmaceuticals, and DuPont, among others.

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

Market Summary

As per MRFR analysis, the Synthetic Biology Market Size was estimated at 18.63 USD Billion in 2024. The Synthetic Biology industry is projected to grow from 23.46 USD Billion in 2025 to 234.78 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 25.9 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Synthetic Biology Market is poised for substantial growth driven by technological advancements and increasing demand across various sectors.

North America remains the largest market for synthetic biology, driven by robust investments in research and development. The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing adoption of innovative biotechnologies. Healthcare continues to dominate the market, while agriculture is rapidly gaining traction as a key growth segment. Rising demand for biopharmaceuticals and innovations in agricultural biotechnology are significant drivers propelling market expansion.

Synthetic Biology Market

CAGR

25.9%

Market Size & Forecast

2024 Market Size	18.63 (USD Billion)
2035 Market Size	234.78 (USD Billion)
CAGR (2025 - 2035)	25.9%
Largest Regional Market Share in 2024	North America

Major Players

<a href="https://www.ginkgo.bio/">Ginkgo Bioworks </a>(US), Amgen (US), DuPont (US), BASF (DE), Synlogic (US), Zymergen (US), Codexis (US), Genomatica (US), Arzeda (US), Novozymes (DK)

Market Trends

The Synthetic Biology Market is currently experiencing a transformative phase characterized by rapid advancements in technology and increasing applications across various sectors. This market encompasses a wide array of disciplines, including genetic engineering, bioinformatics, and metabolic engineering, which collectively contribute to innovative solutions in healthcare, agriculture, and environmental sustainability. The integration of synthetic biology into these fields appears to enhance productivity and efficiency, suggesting a promising trajectory for future growth. Furthermore, the rising demand for sustainable practices and bio-based products is likely to drive further investment and research in this domain, indicating a shift towards more eco-friendly alternatives in industrial processes. In addition, the Synthetic Biology Market is witnessing a surge in collaboration among academic institutions, private enterprises, and governmental bodies. This collaborative approach seems to foster innovation and accelerate the development of new technologies. As regulatory frameworks evolve to accommodate these advancements, the market may experience increased stability and confidence among stakeholders. Overall, the current landscape of the Synthetic Biology Market suggests a dynamic environment ripe for exploration and investment, with the potential to revolutionize multiple industries in the coming years.

Advancements in Genetic Engineering

Recent developments in genetic engineering techniques, such as CRISPR and gene synthesis, are reshaping the Synthetic Biology Market. These innovations enable precise modifications of organisms, leading to enhanced traits in crops and improved therapeutic options in medicine. As these technologies become more accessible, their adoption across various sectors is likely to increase.

Sustainability and Eco-Friendly Solutions

The growing emphasis on sustainability is driving the Synthetic Biology Market towards the development of bio-based products and processes. Companies are increasingly focusing on creating environmentally friendly alternatives to traditional manufacturing methods. This trend not only addresses ecological concerns but also aligns with consumer preferences for sustainable products.

Collaborative Research and Development

The Synthetic Biology Market is characterized by a trend of collaboration among diverse stakeholders, including academia, industry, and government entities. Such partnerships facilitate knowledge sharing and resource pooling, which can accelerate innovation. This collaborative spirit is expected to enhance the market's growth and lead to the emergence of novel applications.

Synthetic Biology Market Market Drivers

Market Growth Projections

The Global Synthetic Biology Market Industry is projected to experience substantial growth over the next decade. With a market value of 11.5 USD Billion in 2024, it is expected to reach 40.2 USD Billion by 2035. This growth trajectory indicates a robust compound annual growth rate (CAGR) of 12.06% from 2025 to 2035. Such projections reflect the increasing adoption of synthetic biology across various sectors, driven by technological advancements, rising demand for sustainable solutions, and enhanced investment in research and development. The market's expansion is indicative of the transformative potential of synthetic biology in addressing global challenges.

Regulatory Support and Frameworks

Regulatory support is emerging as a vital driver for the Global Synthetic Biology Market Industry. Governments are recognizing the potential of synthetic biology to address global challenges and are establishing frameworks to facilitate research and commercialization. This includes guidelines for biosafety and bioethics, which aim to ensure responsible development and application of synthetic biology technologies. Such regulatory clarity not only fosters innovation but also builds public trust, encouraging investment and collaboration across sectors. As regulatory environments become more supportive, the market is likely to experience accelerated growth, paving the way for new applications and technologies.

Growing Applications in Healthcare

The healthcare sector is increasingly leveraging synthetic biology, significantly impacting the Global Synthetic Biology Market Industry. Applications range from the development of novel therapeutics to advanced diagnostic tools. Synthetic biology enables the design of customized medicines and biologics that can target specific diseases more effectively. For instance, engineered microbes are being used to produce insulin and other essential drugs. This trend is likely to continue as the demand for personalized medicine rises, driving market expansion. The integration of synthetic biology into healthcare is expected to contribute to the overall growth of the industry in the coming years.

Rising Demand for Sustainable Solutions

The Global Synthetic Biology Market Industry is witnessing an increasing demand for sustainable solutions across various sectors, including agriculture, energy, and pharmaceuticals. This shift is driven by the need to address environmental challenges and reduce reliance on fossil fuels. For instance, synthetic biology enables the development of biofuels and biodegradable materials, which are essential for a sustainable future. As consumers and industries prioritize eco-friendly practices, the market is projected to reach 11.5 USD Billion in 2024, reflecting a growing commitment to sustainability in production processes.

Advancements in Genetic Engineering Technologies

Technological advancements in genetic engineering are propelling the Global Synthetic Biology Market Industry forward. Innovations such as CRISPR and gene synthesis techniques have revolutionized the ability to manipulate genetic material with precision. These technologies facilitate the creation of engineered organisms that can produce valuable compounds, such as pharmaceuticals and bio-based chemicals. The rapid evolution of these tools is likely to enhance productivity and reduce costs, thereby attracting investment and fostering growth. As a result, the market is expected to expand significantly, with a projected CAGR of 12.06% from 2025 to 2035.

Increased Investment in Research and Development

Investment in research and development is a critical driver of the Global Synthetic Biology Market Industry. Governments and private entities are allocating substantial funds to explore the potential applications of synthetic biology in healthcare, agriculture, and environmental management. For example, initiatives aimed at developing synthetic vaccines and engineered crops are gaining traction, leading to breakthroughs that could transform industries. This influx of funding not only accelerates innovation but also supports the establishment of startups and collaborations, further enhancing market growth. The industry is anticipated to reach 40.2 USD Billion by 2035, underscoring the importance of R&D.

Market Segment Insights

By Application: Healthcare (Largest) vs. Agriculture (Fastest-Growing)

The Synthetic Biology Market displays diverse application segments, with healthcare leading the pack due to its robust demand for innovative therapies and diagnostics. Key areas within healthcare include gene editing, personalized medicine, and biopharmaceuticals, where synthetic biology tools are increasingly being integrated to improve patient outcomes. Following healthcare, agriculture is gaining traction, leveraging synthetic biology for enhanced crop yields, pest resistance, and sustainable practices, thus presenting significant growth potential. As the synthetic biology sector evolves, agriculture is emerging as the fastest-growing segment. This growth is driven by rising global food demands and the need for sustainable agricultural solutions. Innovations in genetically modified organisms and bio-based fertilizers are expected to shape the future of agriculture application in synthetic biology, aligning with environmental sustainability goals and adapting to climate change challenges.

Healthcare (Dominant) vs. Agriculture (Emerging)

In the Synthetic Biology Market, the healthcare application stands out as a dominant force, revolutionizing the medical landscape through advanced therapies and precision medicine. This segment harnesses synthetic biology to develop novel treatments, including gene therapies and personalized drugs, positioning it as a critical area for investment and research. In contrast, the agriculture application is an emerging segment, focusing on the transformation of crop production with synthetic biology innovations. Techniques such as CRISPR and synthetic gene circuits enable the development of crops that are resistant to diseases and environmental stresses, making agriculture a competitive and high-potential area in the synthetic biology market.

By Technology: Gene Editing (Largest) vs. Bioinformatics (Fastest-Growing)

The Synthetic Biology Market is seeing a balanced distribution of market share across various technology segments. Gene Editing remains the largest contributor, driven by the growing demand for precision medicine and agricultural biotechnology. Following closely, Synthetic Genomics and Cellular Engineering are also significant players; however, <a href="https://www.marketresearchfuture.com/reports/bioinformatics-market-2265">Bioinformatics </a>has begun to capture substantial attention due to the increasing need for data analysis in genomics and the overall digital transformation within the sector. Growth trends demonstrate a pivotal shift towards Bioinformatics, primarily led by advancements in big data analytics and machine learning. This segment is projected as the fastest-growing technology, propelled by the pressing need for data-driven solutions in genetic research. Concurrently, the Gene Editing segment continues to thrive owing to innovations in CRISPR technology and other editing tools, fostering an environment ripe for potential breakthroughs and enhanced research efficiency.

Gene Editing: Dominant vs. Cellular Engineering: Emerging

Gene Editing has established itself as the dominant force within the Synthetic Biology Market, characterized by its transformative applications across healthcare, agriculture, and environmental sectors. This segment includes technologies like CRISPR and TALENs, which enable precise modifications in organisms, leading to breakthroughs in disease treatment and crop improvement. Meanwhile, Cellular Engineering, categorized as an emerging sector, focuses on the manipulation of cellular systems for therapeutic purposes, including regenerative medicine and cell therapy. This segment is gaining traction due to the potential for personalized medicine and advanced treatment options, leveraging innovative approaches to understand and harness cellular behavior. As research progresses, both segments hold significant promise, although Gene Editing's established status gives it a current edge.

By End Use: Pharmaceuticals (Largest) vs. Biofuels (Fastest-Growing)

In the Synthetic Biology Market, the End Use segment is notably diverse, comprising Pharmaceuticals, Agricultural Products, Biofuels, Bioplastics, and Food Ingredients. Pharmaceuticals hold the largest market share, driven by advancements in drug development and personalized medicine. Agricultural Products encompass a range of biopesticides and biofertilizers that utilize synthetic biology, contributing significantly to the market but capturing a smaller share compared to pharmaceuticals. Biofuels, while currently less dominant in terms of share, are on a promising growth trajectory, fueled by the global shift towards renewable energy sources.

Pharmaceuticals (Dominant) vs. Biofuels (Emerging)

Pharmaceuticals represent a dominant segment in the Synthetic Biology Market, leveraging synthetic biology techniques for targeted drug therapies and biopharmaceutical production. This segment benefits from continuous innovation and increasing investments in biotechnology. On the other hand, Biofuels, as an emerging segment, are rapidly gaining traction due to the growing demand for sustainable energy options. The innovation in synthetic biology is enhancing the efficiency and effectiveness of biofuel production processes, making it a critical focus area for future energy solutions. As regulations around emissions tighten and consumer preferences shift towards greener solutions, biofuels are expected to capture an increasing share of the market.

Get more detailed insights about Synthetic biology Market Research Report—Global Forecast till 2035

Regional Insights

North America : Innovation and Leadership Hub

North America leads the synthetic biology market with a share of 9.3 billion in 2024, driven by robust investment in biotechnology and supportive regulatory frameworks. The region's growth is fueled by increasing demand for sustainable solutions in agriculture, healthcare, and industrial applications. Government initiatives and funding programs are catalyzing research and development, enhancing the region's competitive edge in synthetic biology innovations. The United States stands out as a key player, hosting major companies like Ginkgo Bioworks, Amgen, and DuPont. The competitive landscape is characterized by a mix of established firms and startups, fostering innovation and collaboration. The presence of leading research institutions further strengthens the ecosystem, ensuring a continuous flow of talent and ideas. As the market evolves, North America is poised to maintain its leadership position in synthetic biology.

Europe : Emerging Regulatory Frameworks

Europe's synthetic biology market is valued at 4.5 billion, reflecting a growing interest in biotechnological advancements and sustainable practices. The region benefits from stringent environmental regulations that encourage the development of eco-friendly solutions. Initiatives like the European Green Deal are pivotal in driving investments and fostering innovation in synthetic biology, aligning with global sustainability goals. Leading countries such as Germany, France, and the UK are at the forefront of this growth, supported by a strong presence of key players like BASF and Novozymes. The competitive landscape is marked by collaborations between academia and industry, enhancing research capabilities. As Europe continues to refine its regulatory frameworks, the synthetic biology market is expected to expand, attracting further investments and innovations.

Asia-Pacific : Rapid Growth and Adoption

The Asia-Pacific synthetic biology market, valued at 3.5 billion, is witnessing rapid growth driven by increasing investments in biotechnology and a rising demand for sustainable solutions. Countries like China and India are leading this trend, supported by government initiatives aimed at enhancing research and development in synthetic biology. The region's diverse agricultural landscape further fuels the demand for innovative biotechnological applications. China is emerging as a significant player, with numerous startups and established companies focusing on synthetic biology applications. The competitive landscape is evolving, with collaborations between local firms and international players. As the region continues to embrace synthetic biology, it is expected to play a crucial role in addressing global challenges such as food security and environmental sustainability.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa synthetic biology market, valued at 1.33 billion, is in its nascent stages but shows significant potential for growth. The region is increasingly recognizing the importance of biotechnology in addressing local challenges, such as food security and healthcare. Government initiatives aimed at fostering innovation and attracting investments are crucial for the sector's development, creating a conducive environment for synthetic biology advancements. Countries like South Africa and the UAE are leading the charge, with growing interest from both local and international players. The competitive landscape is characterized by emerging startups and collaborations with global firms, enhancing the region's capabilities in synthetic biology. As awareness and investment in this sector increase, the Middle East and Africa are poised for substantial growth in the coming years.

Key Players and Competitive Insights

The Synthetic Biology Market is currently characterized by a dynamic competitive landscape, driven by innovation, strategic partnerships, and a growing emphasis on sustainability. Key players such as Ginkgo Bioworks (US), Amgen (US), and Novozymes (DK) are at the forefront, each adopting distinct strategies to enhance their market positioning. Ginkgo Bioworks (US) focuses on leveraging its advanced platform for organism design, which allows for rapid development of custom microbes for various applications, thereby enhancing its competitive edge. Meanwhile, Amgen (US) emphasizes biopharmaceutical innovations, particularly in the realm of synthetic biology, to streamline drug development processes. Novozymes (DK) is strategically positioned in the enzyme production sector, utilizing synthetic biology to optimize its offerings in sustainable agriculture and bioenergy, thus contributing to a more environmentally friendly market approach.

The business tactics employed by these companies reflect a concerted effort to localize manufacturing and optimize supply chains, which is crucial in a moderately fragmented market. This competitive structure allows for a diverse range of innovations and applications, as companies strive to differentiate themselves through unique product offerings and operational efficiencies. The collective influence of these key players fosters a robust environment where collaboration and competition coexist, driving advancements in synthetic biology.

In November 2025, Ginkgo Bioworks (US) announced a strategic partnership with a leading agricultural firm to develop bio-based solutions aimed at enhancing crop resilience. This collaboration is significant as it not only expands Ginkgo's application of synthetic biology in agriculture but also aligns with the increasing demand for sustainable farming practices. The partnership is expected to leverage Ginkgo's expertise in organism design to create innovative solutions that could potentially transform agricultural productivity.

In October 2025, Amgen (US) unveiled a new initiative focused on integrating artificial intelligence (AI) into its synthetic biology research processes. This move is pivotal as it positions Amgen to accelerate drug discovery and development timelines, thereby enhancing its competitive advantage in the biopharmaceutical sector. The incorporation of AI is likely to streamline operations and improve the precision of synthetic biology applications, which could lead to more effective therapies.

In September 2025, Novozymes (DK) launched a new line of enzymes specifically designed for biofuel production, utilizing synthetic biology techniques. This initiative underscores Novozymes' commitment to sustainability and innovation, as it aims to reduce the carbon footprint associated with traditional fuel sources. The introduction of these enzymes is expected to enhance the efficiency of biofuel production, thereby reinforcing Novozymes' position as a leader in sustainable solutions within the synthetic biology market.

As of December 2025, the competitive trends in the Synthetic Biology Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and addressing complex challenges. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. This shift suggests a transformative evolution in the market, where innovation and sustainability will play pivotal roles in shaping future competitive dynamics.

Key Companies in the Synthetic Biology Market market include

Industry Developments

In the first-ever case of a customized CRISPR treatment for a single patient, Acuitas Therapeutics reported in April 2025 that it had successfully used its lipid nanoparticle (LNP) delivery platform to deliver a personalized CRISPR-based gene-editing therapy to a newborn with an extremely rare genetic disorder.In order to strengthen its synthetic biology skills by incorporating Verve Therapeutics' CRISPR-based PCSK9 gene therapy, which recently progressed from Phase I to Phase II studies aimed at cardiovascular illness.

Basecamp Research announced in June 2025 that its environmental DNA (eDNA) sequencing project had identified more than a million new microbial species. These findings were used to train artificial intelligence (AI) models that could create programmable large serine recombinases (LSRs), which could have implications for advanced oncology gene editing.

Constructive Bio, a spin-out from Cambridge University, received $58 million in financing in March 2025 to set up sustainable microbial manufacturing methods for new chemical molecules, including as antibody-drug conjugates and semaglutide precursors.Ginkgo Bioworks solidified its position as a leader in synthetic biology platforms in October 2024 by continuing to grow its "biofoundry" model by collaborating with significant industrial clients to create unique microorganisms for uses ranging from biodegradable materials to self-fertilizing crops.

Future Outlook

Synthetic Biology Market Future Outlook

The Synthetic Biology Market is projected to grow at a 25.9% CAGR from 2024 to 2035, driven by advancements in genetic engineering, increased funding, and rising demand for sustainable solutions.

New opportunities lie in:

Development of customized synthetic organisms for agriculture
Integration of AI in synthetic biology research
Expansion of biomanufacturing facilities for bio-based products

By 2035, the Synthetic Biology Market is poised for substantial growth, reflecting its transformative potential.

Market Segmentation

Synthetic Biology Market End Use Outlook

Pharmaceuticals
Agricultural Products
Biofuels
Bioplastics
Food Ingredients

Synthetic Biology Market Technology Outlook

Gene Editing
Synthetic Genomics
Bioinformatics
Metabolic Engineering
Cellular Engineering

Synthetic Biology Market Application Outlook

Healthcare
Agriculture
Industrial Biotechnology
Environmental Management
Food and Beverage

Report Scope

MARKET SIZE 2024	18.63(USD Billion)
MARKET SIZE 2025	23.46(USD Billion)
MARKET SIZE 2035	234.78(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	25.9% (2024 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Ginkgo Bioworks (US), Amgen (US), DuPont (US), BASF (DE), Synlogic (US), Zymergen (US), Codexis (US), Genomatica (US), Arzeda (US), Novozymes (DK)
Segments Covered	Application, Technology, End Use
Key Market Opportunities	Advancements in gene editing technologies drive innovation in the Synthetic Biology Market.
Key Market Dynamics	Technological advancements and regulatory shifts drive innovation and competition in the Synthetic Biology Market.
Countries Covered	North America, Europe, APAC, South America, MEA